• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • NORTH AMERICA EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • NORTH AMERICA EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Life Science Market
Life Science News
Life Science Stocks
  • Life Science Market
  • Life Science News
  • Life Science Stocks

Increase in Child Allergies Prompts Release of New Weaning Guidelines

Investing News Network
Dec. 14, 2012 03:09PM PST
Life Science Investing

The Australian reported that the National Health and Medical Research Council or NHMRC is set to release new weaning guidelines, which will loosen up on its recommendation that babies should be breastfed exclusively in their first six months.

The Australian reported that the National Health and Medical Research Council or NHMRC is set to release new weaning guidelines, which will loosen up on its recommendation that babies should be breastfed exclusively in their first six months.

As quoted in the market news:

“The NHMRC’s existing limit of six months mirrors that of the World Health Organisation, but clashes with advice from Australia’s top allergy specialists.

The Australasian Society of Clinical Immunology and Allergy says parents should start introducing solid foods from the age of four months, in addition to breastmilk.”

Click here to read the full The Australian report.

australia life-science-investing
The Conversation (0)

Go Deeper

AI Powered
Various colorful pills and tablets scattered from a brown bottle on a blue background.

Pharma Market Forecast: Top Trends for Pharma in 2026

Life Science Outlook: World Edition

Life Science Outlook: World Edition

Latest News

InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update

Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure

More News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Life Science Investing Stocks

More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES